Русский
Estimation of adherence to treatment among patients with arterial hypertension based on therapeutic drug monitoring data
DOI: https://dx.doi.org/10.18565/therapy.2024.9.32-38
Seleznev S.V., Mylnikov P.Yu., Shchulkin A.V., Yakushin S.S.
Academician I.P. Pavlov Ryazan State Medical University of the Ministry of Healthcare of Russia
The aim: to determine patient adherence to antihypertensive therapy using therapeutic drug monitoring (TDM) and compare the obtained data with the results of adherence estimation using the Questionnaire for Quantitative Estimation of Adherence to Treatment.
Material and methods. A clinical, cross-sectional, controlled study was performed at regional clinical cardiology dispensary (Ryazan). It included patients over 18 years of age with proven diagnosis of arterial hypertension. The level of blood pressure (BP) was fixed according to the data of daily blood pressure monitoring (DBPM). Adherence to treatment was assessed using the Questionnaire for Quantitative Estimation of Adherence to Treatment and determination of the concentration of metoprolol, lisinopril, amlodipine, valsartan and indapamide in the blood serum (TDM).
Results. The study included 183 individuals (78 male and 105 female patients, their average age was 63.4 ± 11.1 years). Uncontrolled hypertension group included 98 patients. Control criteria were the target values of average systolic, diastolic BP during the day and at night according to DBPM results. According to TDM data, the majority of patients had high adherence – more than 80%. Statistically significant differences were noted in the uncontrolled and controlled hypertension groups in the frequency of average adherence to lisinopril therapy. According to the data of the Questionnaire for Quantitative Estimation of Adherence to Treatment, the frequency of high adherence to treatment averaged 21.3% and did not differ in the uncontrolled and controlled hypertension groups. When comparing the results according to the Questionnaire for Quantitative Estimation of Adherence to Treatment and TDM data, coincidence was observed in less than a quarter of cases.
Conclusion. The results of assessing patients’ adherence to treatment using serum drug concentration monitoring coincide with the data of the Questionnaire for Quantitative Estimation of Adherence to Treatment in less than a quarter of cases in case of controlled arterial hypertension (10.0–26.7%), which is slightly higher than in case of uncontrolled hypertension (9.1–16.7%).
Literature
1. Ettehad D., Emdin C.A., Kiran A. et al. Blood pressure lowering for prevention of cardiovascular disease and death: A systematic review and meta-analysis. Lancet. 2016; 387(10022): 957–67. https://doi.org/10.1016/S0140-6736(15)01225-8. PMID: 26724178. 2. Бойцов С.А., Баланова Ю.А., Шальнова С.А. с соавт. Артериальная гипертония среди лиц 25–64 лет: распространенность, осведомленность, лечение и контроль. По материалам исследования ЭССЕ. Кардиоваскулярная терапия и профилактика. 2014; 13(4): 4–14. (Boitsov S.A., Balanova Yu.A., Shalnova S.A. et al. Arterial hypertension among individuals of 25–64 years old: Prevalence, awareness, treatment and control. By the data from ECCD. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention. 2014; 13(4): 4–14 (In Russ.)). https://doi.org/10.15829/1728-8800-2014-4-4-14. EDN: SLQTRD. 3. Poulter N.R., Borghi C., Parati G. et al. Medication adherence in hypertension. J Hypertens. 2020; 38(4): 579–87. https://doi.org/10.1097/hjh.0000000000002294. PMID: 31834123. 4. Сeral J., Habrdova V., Vorisek V. et al. Difficult-to-control arterial hypertension or uncooperative patients? The assessment of serum antihypertensive drug levels to differentiate nonresponsiveness from non-adherence to recommended therapy. Hypertens Res. 2011; 34(1): 87–90. https://doi.org/10.1038/hr.2010.183. PMID: 20882030. 5. Jung O., Gechter J.L., Wunder C. et al. Resistant hypertension? Assessment of adherence by toxicological urine analysis. J Hypertens. 2013; 31(4): 766–74. https://doi.org/10.1097/HJH.0b013e32835e2286. PMID: 23337469. 6. Strauch B., Petrák O., Zelinka T. et al. Precise assessment of noncompliance with the antihypertensive therapy in patients with resistant hypertension using toxicological serum analysis. J Hypertens. 2013; 31(12): 2455–61. https://doi.org/10.1097/HJH.0b013e3283652c61. PMID: 24220593. 7. Hamdidouche I., Jullien V., Boutouyrie P. et al. Routine urinary detection of antihypertensive drugs for systematic evaluation of adherence to treatment in hypertensive patients. J Hypertens. 2017; 35(9): 1891–98. https://doi.org/10.1097/hjh.0000000000001402. PMID: 28505066. 8. Eskas P.A., Heimark S., Mariampillai J.E. et al. Adherence to medication and drug monitoring in apparent treatment-resistant hypertension. Blood Pressure. 2016; 25(4): 199–205. https://doi.org/10.3109/08037051.2015.1121706. PMID: 26729283. 9. Morisky D.E., Green L.W., Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986; 24(1): 67–74. https://doi.org/10.1097/00005650-198601000-00007. PMID: 3945130. 10. Kim M.T., Hill M.N., Bone L.R., Levine D.M. Development and testing of the Hill – Bone compliance to high blood pressure therapy scale. Prog Cardiovasc Nurs. 2000; 15(3): 90–96. https://doi.org/10.1111/j.1751-7117.2000.tb00211.x. PMID: 10951950. 11. Николаев Н.А., Мартынов А.И., Драпкина О.М. с соавт. Первый российский консенсус по количественной оценке приверженности к лечению. Терапия. 2018; 4(5): 11–32. (Nikolaev N.A., Martynov A.I., Drapkina O.M. et al. The first Russian consensus on the quantitative assessment of the adherence to treatment. Terapiya = Therapy. 2018; 4(5): 11–32 (In Russ.)). https://dx.doi.org/10.18565/therapy.2018.5.11-32. EDN: YHMDNB. 12. Correa N.B., de Faria A.P., Ritter A.M. et al. A practical approach for measurement of antihypertensive medication adherence in patients with resistant hypertension. J Am Soc Hypertens. 2016; 10(6): 510–516.e1. https://doi.org/10.1016/j.jash.2016.03.194. PMID: 27161936. 13. Клинические рекомендации. Артериальная гипертензия у взрослых. Общероссийская общественная организация «Российское кардиологическое общество». Рубрикатор клинических рекомендаций Минздрава России. 2020. ID: 62. Доступ: https://cr.minzdrav.gov.ru/recomend/62_2 (дата обращения – 28.10.2024). (Clinical guidelines. Arterial hypertension in adults. Russian Society of Cardiology. Rubricator of clinical guidelines of the Ministry of Healthcare of Russia. 2020. ID: 62. URL: https://cr.minzdrav.gov.ru/recomend/62_2 (date of access – 28.10.2024) (In Russ.)). 14. Леонова М.В. К вопросу о низкой приверженности пациентов антигипертензивной терапии: применение терапевтического лекарственного мониторинга препаратов. Consilium Medicum. 2022; 24(10): 682–686. (Leonova M.V. On the issue of low adherence of patients to antihypertensive therapy: The use of therapeutic drug monitoring of drugs. Consilium Medicum. 2022; 24(10): 682–686 (In Russ.)). https://doi.org/10.26442/20751753.2022.10.201872. EDN: EZFIOK. 15. Мыльников П.Ю., Щулькин А.В., Селезнев С.В. с соавт. Разработка и валидация метода количественного определения лизиноприла, индапамида, метопролола, валсартана и амлодипина в сыворотке крови людей методом ВЭЖХ-МС/МС. Химико-фармацевтический журнал. 2024; 58(3): 49–53 (Mylnikov P.Yu., Shchulkin A.V., Seleznev S.V. et al. Development and validation of a method for quantitative determination of lisinopril, indapamide, metoprolol, valsartan and amlodipine in human serum by HPLC-MS/MS. Khimiko-farmatsevticheskiy zhurnal = Pharmaceutical Chemistry Journal. 2024; 58(3): 49–53 (In Russ.)). https://doi.org/10.30906/0023-1134-2024-58-3-49-53. EDN: LYOPVV. 16. Реброва О.Ю. Статистический анализ медицинских данных. Применение пакета прикладных программ STATISTICA. М.: МедиаСфера. 2002; 312 с. (Rebrova O.Yu. Statistical analysis of medical data. Application of the STATISTICA software package. Moscow: MediaSphere. 2002; 312 pp. (In Russ.)). ISBN: 5-89084-013-4. 17. Florczak E., Tokarczyk B., Warchoł-Celińska E. et al. Assessment of adherence to treatment in patients with resistant hypertension using toxicological serum analysis. A subgroup evaluation of the RESIST-POL study. Pol Arch Med Wewn. 2015; 125(1–2): 65–72. https://doi.org/10.20452/pamw.2648. PMID: 25578261. 18. Bergland O.U., Halvorsen L.V., Søraas C.L. et al. Detection of nonadherence to antihypertensive treatment by measurements of serum drug concentrations. Hypertension. 2021; 78(3): 617–28. https://doi.org/10.1161/hypertensionaha.121.17514. PMID: 34275336.
About the Autors
Sergey V. Seleznev, MD, PhD (Medicine), associate professor, associate professor of the Department of hospital therapy with the course of medical and social expertise, Academician I.P. Pavlov Ryazan State Medical University of the Ministry of Healthcare of Russia. Address: 390026, Ryazan, 96 Stroykova St.
E-mail: sv.seleznev@gmail.com
ORCID: https://orcid.org/0000-0002-4069-8082
Pavel Yu. Mylnikov, MD, PhD (Biology), associate professor of the Department of pharmacology, Academician I.P. Pavlov Ryazan State Medical University of the Ministry of Healthcare of Russia. Address: 390026, Ryazan, 34/2 Shevchenko St.
E-mail: dukeviperlr@gmail.com
ORCID: https://orcid.org/0000-0001-7829-2494
Alexey V. Shchulkin, MD, Dr. Sci. (Medicine), associate professor, professor of the Department of pharmacology, Academician I.P. Pavlov Ryazan State Medical University of the Ministry of Healthcare of Russia. Address: 390026, Ryazan, 34/2 Shevchenko St.
E-mail: alekseyshulkin@rambler.ru
ORCID: https://orcid.org/0000-0003-1688-0017
Sergey S. Yakushin, MD, Dr. Sci. (Medicine), professor, head of the Department of hospital therapy with a course in medical and social expertise, Academician I.P. Pavlov Ryazan State Medical University of the Ministry of Healthcare of Russia. Address: 390026, Ryazan, 96 Stroykova St.
E-mail: prof.yakushin@gmail.com
ORCID: https://orcid.org/0000-0002-1394-3791
Similar Articles
